From Proteopedia
proteopedia linkproteopedia link
NSAIDs
Drug
| Coefficient of selectivity (IC50Cox-1/IC50Cox-2)
|
Ketorolac
| 100-1000
|
Naproxen
| 1-10
|
Ibuprofen
| 1-10
|
Indometacin
| 1-10
|
Acetylsalicylic acid
| 1
|
Diclofenac
| 1-0.1
|
Valdecoxib
| 0.01-0.001
|
Etoricoxib
| 0.01-0.001
| Table X: Selectivity of some NSAIDs
Pharmacologic group
| Drug
|
Salicylates | Acetylsalicylic acid
|
Propionic
| Naproxen
|
Ibuprofen
|
Para-aminophenols | Paracetamol
|
Indolacetic | Indometacin
|
Pirrolacetic | Ketorolac
|
Phenilacetic | Diclofenac
|
Piranoidacetic | Etodolac
|
Anthranilic | Mefenamic acid
|
Nicotinic | Clonixin
|
Sulfonanilides | Nimesulide
| Table X: Chemical variety of NSAIDs
Reference
- Ghosh N, Chaki R, Mandal V, Mandal SC. COX-2 as a target for cancer chemotherapy. Pharmacol Rep. 2010 Mar-Apr;62(2):233-44. PMID:20508278
- Rang HP, Dale MM, Ritter JM, Flower RJ. 2008. Pharmacology. Elsevier. 6th edition. 844 p.
- Smith WL, Langenbach R. Why there are two cyclooxygenase isozymes. J Clin Invest. 2001 Jun;107(12):1491-5. PMID:11413152 doi:10.1172/JCI13271
- Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, Simmons DL. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13926-31. Epub 2002 Sep 19. PMID:12242329 doi:10.1073/pnas.162468699
- Perrone G, Zagami M, Altomare V, Battista C, Morini S, Rabitti C. COX-2 localization within plasma membrane caveolae-like structures in human lobular intraepithelial neoplasia of the breast. Virchows Arch. 2007 Dec;451(6):1039-45. Epub 2007 Sep 13. PMID:17851687 doi:10.1007/s00428-007-0506-4
- Spencer AG, Thuresson E, Otto JC, Song I, Smith T, DeWitt DL, Garavito RM, Smith WL. The membrane binding domains of prostaglandin endoperoxide H synthases 1 and 2. Peptide mapping and mutational analysis. J Biol Chem. 1999 Nov 12;274(46):32936-42. PMID:10551860
- Luong C, Miller A, Barnett J, Chow J, Ramesha C, Browner MF. Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2. Nat Struct Biol. 1996 Nov;3(11):927-33. PMID:8901870
- Kurumbail RG, Stevens AM, Gierse JK, McDonald JJ, Stegeman RA, Pak JY, Gildehaus D, Miyashiro JM, Penning TD, Seibert K, Isakson PC, Stallings WC. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature. 1996 Dec 19-26;384(6610):644-8. PMID:8967954 doi:http://dx.doi.org/10.1038/384644a0